Physician Assistant · Houston, TX
NPI
1841682390
Since 2015
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6414 Fannin St Ste G150
Houston, TX, 77030
Phone (713) 486-7560
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
371 services
Medicare patients, 2024
267
Average age 74
Drug cost, 2024
$1.4M
484 prescriptions
Company payments, 2025
$23K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina Yazdani was code 99214 (office e&m - established), 259 times for 222 patients. In total Christina Yazdani billed 371 services in 6 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 259 | 222 | $73.32 | $19K |
| 99215 Office E&M - Established | Office | 79 | 78 | $115.94 | $9,159 |
| 99204 Office E&M - New | Office | 25 | 25 | $85.70 | $2,143 |
By year: 2022 $41K for 458 services; 2023 $41K for 466 services; 2024 $30K for 371 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina Yazdani prescribed most often to Medicare patients was Tymlos (Abaloparatide), with 225 prescriptions and refills. In total Christina Yazdani wrote 484 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tymlos Abaloparatide | 225 | 299 | 40 | $792K |
| Teriparatide Generic | 83 | 119 | 15 | $320K |
| Prolia Denosumab | 46 | 276 | 30 | $79K |
| Evenity (2 Syringes) Romosozumab-Aqqg | 34 | 34 | Under 11 | $83K |
| Alendronate Sodium Generic | 31 | 85 | 14 | $382 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 22 | 43 | Under 11 | $683 |
| Forteo Teriparatide | 16 | 20 | Under 11 | $88K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 14 | 37 | Under 11 | $266 |
Brand drugs: 374 claims; generic drugs: 86 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina Yazdani $23K ($23K in general payments such as food, travel and fees) from 7 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.